Supplementation of pancreatic digestive enzymes alters the composition of intestinal microbiota in mice

Posted by: | November 2, 2023 | Comments

•Oral supplementation of pancrelipase alters composition of intestinal microbiota.
•Over-represented taxa include bacteria promoting intestinal homeostasis.
•Akkermansia muciniphila and Lactobacillus reuteri are over-represented.
•Pro-inflammatory bacteria is inhibited by supplementation of pancrelipase.
•Pancrelipase may help treat chronic pancreatitis by altering intestinal microbiota.

Although pancreatic enzyme replacement therapy (PERT) is effective in the alleviation of pancreatic exocrine insufficiency (PEI)-related symptoms in patients with chronic pancreatitis, its mechanism of action is poorly understood. Recent studies suggest that the intestinal microbiota is associated with the pathogenesis of chronic pancreatitis. Therefore, we hypothesized that PERT exerts its effect by modifying the intestinal microbiota in addition to its presumed role in promoting fat and protein absorption. To explore the mechanism of action of PERT, we analyzed the intestinal microbiotas of two groups of mice treated with either pancrelipase or tap water by using 16S rRNA amplicon sequencing. The results revealed that the bacterial compositions of the pancrelipase-treated mice were significantly different from those of the control samples. Akkermansia muciniphila, a key beneficial bacterium in the intestinal tract, showed a higher relative abundance in the pancrelipase-treated samples than in the control samples. Lactobacillus reuteri, a widely used probiotic bacterium known to relieve intestinal inflammation, also showed a higher relative abundance in the pancrelipase-treated samples. These results suggested that PERT induces the colonization of beneficial bacteria, thereby contributing to the attenuation of PEI-associated symptoms in addition to improvement of the nutritional state.

Discover More: Science Direct

Hiroki Nishiyamaa, Tomoyuki Nagaib, Masatoshi Kudo, Yoshihisa Okazaki, Yoshinao Azuma, Tomohiro Watanabe, Susumu Goto, Hiroyuki Ogata, Toshiharu Sakuraib. Biochemical and Biophysical Research Communications. Available online 26 October 2017.

Stay up-to-date!
Email Address *
First Name
Last Name

* indicates required
Privacy Policy

Terms & Conditions | Privacy Policy | © 2021 The Translational Microbiome Research Forum

As of 3/31 the forum will no longer be active. Please visit for future bioscience events as Taconic remains committed to leading the industry in microbiome solutions. Thank you for your support.